Navigation Links
Cancer Research UK's new funding scheme to nurture future world-leading scientists
Date:7/2/2014

A NEW funding scheme will support mid-career scientists looking to take the next steps in their careers, at a point when funding opportunities can be limited.

Cancer Research UK's Programme Foundation Award* will bridge the gap for researchers who have the potential to be the next world-leaders in cancer research but not yet at the level to compete with senior scientists for Cancer Research UK's Programme Awards the largest award Cancer Research UK makes to research groups.

This award is the first of Cancer Research UK's increased investment in research announced as part of its new research strategy.

The Programme Foundation Award will provide funding of up to 1.5 million over six years. The funding will cover staff salaries, PhD students, running costs and equipment. Typically a researcher will have around eight to 14 years post-doctoral experience when applying for the award.

Dr Iain Foulkes, Cancer Research UK's executive director of strategy and research funding, said: "Researchers are vital for what we do we rely on their curiosity, passion and questioning to make the breakthroughs that will help more people survive cancer. But for many years there has been a 'missing link' in funding schemes to take researchers from the early stages in their career to being the leading stars of cancer research. The Programme Foundation Award will bridge this gap."

Cancer Research UK is also changing the eligibility criteria for another of its awards the Career Establishment Award. This will now support researchers for six years, rather than five, meaning that there are funding opportunities for scientists at all stages of their careers with holders of the Career Establishment Awards expected to progress onto the Programme Foundation Award.

Supporting researchers at all stages of their careers has long been at the heart of Cancer Research UK's work with over 35 million spent each year helping to develop the research leaders of tomorrow. This month the charity supported the largest number ever of awards to support researchers taking the next steps in their careers. This includes seven Career Development Fellowships, two Career Establishment Awards, two Senior Cancer Research Fellowships and five Clinician Scientist Fellowships.

The Programme Foundation Award forms part of Cancer Research UK's ambitious new research strategy. The charity will invest up to 50 million a year in a range of new funding schemes covering some of the biggest questions in cancer research. These will range from schemes to develop the next generation of researchers to those addressing specific research questions to improve our understanding of the disease and find better and kinder treatments.

Professor Nic Jones, Cancer Research UK's chief scientist, said: "The new Programme Foundation Award positions the UK as one of the best places in the world for a scientist to develop their career in cancer research. We want to recruit the best people and help them grow at every step of their career. The medical breakthroughs of tomorrow start with investment in today's cancer researchers. This is how we will get to our aim of getting three-quarters of people surviving cancer in the next 20 years."


'/>"/>

Contact: Simon Shears
simon.shears@cancer.org.uk
44-203-469-8054
Cancer Research UK
Source:Eurekalert

Related medicine news :

1. Biomarker predicts effectiveness of brain cancer treatment
2. GW researcher receives more than $1 million in grants to study epigenetics of pancreatic cancer
3. For cancer patients, sugar-coated cells are deadly
4. Mayo Clinic: Proton therapy has advantages over IMRT for advanced head and neck cancers
5. Mayo Clinic researchers reveal treasure trove of genes key to kidney cancer
6. Enlightening cancer cells
7. Cancer risk: Aspirin and smoking affect aging of genes
8. EORTC presents European solution for effective cancer drug development
9. New approach identifies cancer mutations as targets of effective melanoma immunotherapy
10. Case Western Reserve, University Hospitals fundraising for adolescent, young adult cancer
11. Improved survival with TAS-102 in mets colorectal cancer refractory to standard therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Pro X users can now reveal the media of their split screens with ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  Guerbet announced today that ... Supplier Horizon Award . One of ... was recognized for its support of Premier members through ... clinical excellence, and commitment to lower costs. ... this recognition of our outstanding customer service from Premier," ...
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
(Date:6/23/2016)... , June 23, 2016 The ... it continues to present great opportunities to investors. Stock-Callers.com ... today: Intrexon Corp. (NYSE: XON ), Vertex ... Inc. (NASDAQ: ARNA ), and Regeneron Pharmaceuticals ... these stocks and receive your complimentary trade alerts at: ...
Breaking Medicine Technology: